Autologous immune enhancement therapy: A case report of a stage IV colonic cancer
Open Access
- 12 March 2013
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 5 (5) , 1611-1614
Abstract
Current modalities of cancer treatment, including surgery, chemotherapy and radiotherapy, show marginal therapeutic responses in cancer patients. In adoptive immunotherapy, interleukin-2 (IL-2) activated immune cells demonstrated notable results in patients with advanced malignant disease. The present study reports the efficacy and safety of repetitive infusions of autologous immune enhancement therapy (AIET) in a stage IV colonic cancer patient who had already received first-line chemotherapeutic drugs. Peripheral blood was aspirated from the patient. Specifically, natural killer (NK) cells and T-lymphocytes were isolated from the peripheral blood mononuclear cells (PBMCs). These cells were activated and expanded ex vivo for 14 days and were transfused intravenously to the patient. After six infusions of AIET, the carcinoembryonic antigen (CEA) level was decreased from 901 to 437 U/ml, regression of lesions was noted and there were no adverse reactions during the course of this therapy. Thus, AIET may be a promising anticancer approach to eradicate tumor cells with other conventional therapies.Keywords
This publication has 36 references indexed in Scilit:
- B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in MiceThe Journal of Immunology, 2010
- Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator PhenotypeClinical Cancer Research, 2009
- Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral InfectionsInternational Reviews of Immunology, 2008
- Transferable anticancer innate immunity in spontaneous regression/complete resistance miceProceedings of the National Academy of Sciences, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Palliative Therapie des kolorektalen KarzinomsOncology Research and Treatment, 2003
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- The enigma of the natural killer cellNature, 1995
- Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancerEuropean Journal of Cancer, 1993